NCT04682743View on ClinicalTrials.gov

Prevention of Post-Operative Shivering

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

January 16, 2022

Study Completion Date

February 22, 2022

Conditions
Post-Operative Shivering
Interventions
DRUG

paracetamol

received intravenous one gram of paracetamol over a 15-minute period,

DRUG

ondansetron

received intravenous 8 mg of ondansetron over a 15-minute period.

DRUG

normal saline

received intravenous 0.9% normal saline over a 15-minute period.

Trial Locations (1)

11562

Cairo university, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT04682743 - Prevention of Post-Operative Shivering | Biotech Hunter | Biotech Hunter